Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 4, 2013, Pages 3067-3076

  Chiang, Chi Hsiang ^a   Hou, Ming Feng ^b,d   Hung, Wen Chun ^c,d  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

catenin; Matrix metalloproteinase; MicroRNA; miR 182; Reversion inducing cysteine rich protein with Kazal motif (RECK)

Indexed keywords

BETA CATENIN; GELATINASE B; MESSENGER RNA; MICRORNA 182; REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL MOTIF; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CARCINOGENICITY; CHROMATIN IMMUNOPRECIPITATION; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; RECK GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

ADULT; AGED; BETA CATENIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GPI-LINKED PROTEINS; HUMANS; MATRIX METALLOPROTEINASE INHIBITORS; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84873734483     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.01.009     Document Type: Article

References (52)

1. A. Esquela-Kerscher, and F.J. Slack Oncomirs - microRNAs with a role in cancer Nat. Rev. Cancer 6 2006 259 269
2. G.A. Calin, C.D. Dumitru, M. Shimizu, R. Bichi, S. Zupo, E. Noch, H. Aldler, S. Rattan, M. Keating, K. Rai, L. Rassenti, T. Kipps, M. Negrini, F. Bullrich, and C.M. Croce Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proc. Natl. Acad. Sci. U. S. A. 99 2002 15524 15529
3. J. Takamizawa, H. Konishi, K. Yanagisawa, S. Tomida, H. Osada, H. Endoh, T. Harano, Y. Yatabe, M. Nagino, Y. Nimura, T. Mitsudomi, and T. Takahashi Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival Cancer Res. 64 2004 3753 3756
4. M.V. Iorio, M. Ferracin, C.G. Liu, A. Veronese, R. Spizzo, S. Sabbioni, E. Magri, M. Pedriali, M. Fabbri, M. Campiglio, S. Menard, J.P. Palazzo, A. Rosenberg, P. Musiani, S. Volinia, I. Nenci, G.A. Calin, P. Querzoli, M. Negrini, and C.M. Croce MicroRNA gene expression deregulation in human breast cancer Cancer Res. 65 2005 7065 7070
5. L. Ma, J. Teruya-Feldstein, and R.A. Weinberg Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 449 2007 682 688
6. S. Xu, P.D. Witmer, S. Lumayag, B. Kovacs, and D. Valle MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster J. Biol. Chem. 282 2007 25053 25066
7. M.F. Segura, D. Hanniford, S. Menendez, L. Reavie, X. Zou, S. Alvarez-Diaz, J. Zakrzewski, E. Blochin, A. Rose, D. Bogunovic, D. Polsky, J. Wei, P. Lee, I. Belitskaya-Levy, N. Bhardwaj, I. Osman, and E. Hernando Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor Proc. Natl. Acad. Sci. U. S. A. 106 2009 1814 1819
8. I.K. Guttilla, and B.A. White Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells J. Biol. Chem. 284 2009 23204 23216
9. B.N. Hannafon, P. Sebastiani, A. de las Morenas, J. Lu, and C.L. Rosenberg Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer Breast Cancer Res. 13 2011 R24
10. O. Giricz, P.A. Reynolds, A. Ramnauth, C. Liu, T. Wang, L. Stead, G. Childs, T. Rohan, N. Shapiro, S. Fineberg, P.A. Kenny, and O. Loudig Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity J. Pathol. 226 2012 108 119
11. L. Jiang, P. Mao, L. Song, J. Wu, J. Huang, C. Lin, J. Yuan, L. Qu, S.Y. Cheng, and J. Li miR-182 as a prognostic marker for glioma progression and patient survival Am. J. Pathol. 177 2010 29 38
12. B.L. Mihelich, E.A. Khramtsova, N. Arva, A. Vaishnav, D.N. Johnson, A.A. Giangreco, E. Martens-Uzunova, O. Bagasra, A. Kajdacsy-Balla, and L. Nonn miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells J. Biol. Chem. 286 2011 44503 44511
13. J. Wang, J. Li, J. Shen, C. Wang, L. Yang, and X. Zhang MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma BMC Cancer 12 2012 227
14. P. Moskwa, F.M. Buffa, Y. Pan, R. Panchakshari, P. Gottipati, R.J. Muschel, J. Beech, R. Kulshrestha, K. Abdelmohsen, D.M. Weinstock, M. Gorospe, A.L. Harris, T. Helleday, and D. Chowdhury miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors Mol. Cell 41 2011 210 220
15. Z. Liu, J. Liu, M.F. Segura, C. Shao, P. Lee, Y. Gong, E. Hernando, and J.J. Wei MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma J. Pathol. 228 2012 204 215
16. T. Reya, and H. Clevers Wnt signalling in stem cells and cancer Nature 434 2005 843 850
17. A. Incassati, A. Chandramouli, R. Eelkema, and P. Cowin Key signaling nodes in mammary gland development and cancer: beta-catenin Breast Cancer Res. 12 2010 213
18. L.R. Howe, and A.M. Brown Wnt signaling and breast cancer Cancer Biol. Ther. 3 2004 36 41
19. A.M. Brown Wnt signaling in breast cancer: have we come full circle? Breast Cancer Res. 3 2001 351 355
20. A. Gokhale, R. Kunder, A. Goel, R. Sarin, A. Moiyadi, A. Shenoy, C. Mamidipally, S. Noronha, S. Kannan, and N.V. Shirsat Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway J. Cancer Res. Ther. 6 2010 521 529
21. L.T. Liu, H.C. Chang, L.C. Chiang, and W.C. Hung Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion Cancer Res. 63 2003 3069 3072
22. M.C. Hsu, C.C. Huang, H.C. Chang, T.H. Hu, and W.C. Hung Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo Clin. Cancer Res. 14 2008 4045 4052
23. M.R. Pan, H.C. Chang, Y.C. Wu, C.C. Huang, and W.C. Hung Tubocapsanolide A inhibits transforming growth factor-beta-activating kinase 1 to suppress NF-kappaB-induced CCR7 J. Biol. Chem. 284 2009 2746 2754
24. L.T. Liu, J.P. Peng, H.C. Chang, and W.C. Hung RECK is a target of Epstein-Barr virus latent membrane protein 1 Oncogene 22 2003 8263 8270
25. S. Handeli, and J.A. Simon A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities Mol. Cancer Ther. 7 2008 521 529
26. M. Vaid, R. Prasad, Q. Sun, and S.K. Katiyar Silymarin targets beta-catenin signaling in blocking migration/invasion of human melanoma cells PLoS One 6 2011 e23000
27. A.B. Stittrich, C. Haftmann, E. Sgouroudis, A.A. Kuhl, A.N. Hegazy, I. Panse, R. Riedel, M. Flossdorf, J. Dong, F. Fuhrmann, G.A. Heinz, Z. Fang, N. Li, U. Bissels, F. Hatam, A. Jahn, B. Hammoud, M. Matz, F.M. Schulze, R. Baumgrass, A. Bosio, H.J. Mollenkopf, J. Grun, A. Thiel, W. Chen, T. Hofer, C. Loddenkemper, M. Lohning, H.D. Chang, N. Rajewsky, A. Radbruch, and M.F. Mashreghi The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes Nat. Immunol. 11 2010 1057 1062
28. G. Li, C. Luna, J. Qiu, D.L. Epstein, and P. Gonzalez Alterations in microRNA expression in stress-induced cellular senescence Mech. Ageing Dev. 130 2009 731 741
29. M. Noda, J. Oh, R. Takahashi, S. Kondo, H. Kitayama, and C. Takahashi RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling Cancer Metastasis Rev. 22 2003 167 175
30. N. Meng, Y. Li, H. Zhang, and X.F. Sun RECK, a novel matrix metalloproteinase regulator Histol. Histopathol. 23 2008 1003 1010
31. J.C. Clark, D.M. Thomas, P.F. Choong, and C.R. Dass RECK - a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer Cancer Metastasis Rev. 26 2007 675 683
32. C. Takahashi, Z. Sheng, T.P. Horan, H. Kitayama, M. Maki, K. Hitomi, Y. Kitaura, S. Takai, R.M. Sasahara, A. Horimoto, Y. Ikawa, B.J. Ratzkin, T. Arakawa, and M. Noda Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK Proc. Natl. Acad. Sci. U. S. A. 95 1998 13221 13226
33. H.C. Chang, L.T. Liu, and W.C. Hung Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK Cell. Signal. 16 2004 675 679
34. M.C. Hsu, H.C. Chang, and W.C. Hung HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion J. Biol. Chem. 281 2006 4718 4725
35. H.C. Chang, C.Y. Cho, and W.C. Hung Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation Cancer Res. 66 2006 8413 8420
36. P.L. Depowski, S.I. Rosenthal, and J.S. Ross Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer Mod. Pathol. 14 2001 672 676
37. G.M. Wulf, A. Ryo, G.G. Wulf, S.W. Lee, T. Niu, V. Petkova, and K.P. Lu Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1 EMBO J. 20 2001 3459 3472
38. S. Ozaki, S. Ikeda, Y. Ishizaki, T. Kurihara, N. Tokumoto, M. Iseki, K. Arihiro, T. Kataoka, M. Okajima, and T. Asahara Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer Oncol. Rep. 14 2005 1437 1443
39. C.P. Prasad, G. Rath, S. Mathur, D. Bhatnagar, and R. Ralhan Potent growth suppressive activity of curcumin in human breast cancer cells: modulation of Wnt/beta-catenin signaling Chem. Biol. Interact. 181 2009 263 271
40. C.C. Liu, J. Prior, D. Piwnica-Worms, and G. Bu LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy Proc. Natl. Acad. Sci. U. S. A. 107 2010 5136 5141
41. F.C. Geyer, M. Lacroix-Triki, K. Savage, M. Arnedos, M.B. Lambros, A. MacKay, R. Natrajan, and J.S. Reis-Filho beta-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation Mod. Pathol. 24 2011 209 231
42. L. Yang, X. Wu, Y. Wang, K. Zhang, J. Wu, Y.C. Yuan, X. Deng, L. Chen, C.C. Kim, S. Lau, G. Somlo, and Y. Yen FZD7 has a critical role in cell proliferation in triple negative breast cancer Oncogene 30 2011 4437 4446
43. T.D. King, M.J. Suto, and Y. Li The Wnt/beta-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer J. Cell. Biochem. 113 2012 13 18
44. L. Song, L. Liu, Z. Wu, Y. Li, Z. Ying, C. Lin, J. Wu, B. Hu, S.Y. Cheng, M. Li, and J. Li TGF-beta induces miR-182 to sustain NF-kappaB activation in glioma subsets J. Clin. Invest. 122 2012 3563 3578
45. C. Huynh, M.F. Segura, A. Gaziel-Sovran, S. Menendez, F. Darvishian, L. Chiriboga, B. Levin, D. Meruelo, I. Osman, J. Zavadil, E.G. Marcusson, and E. Hernando Efficient in vivo microRNA targeting of liver metastasis Oncogene 30 2011 1481 1488
46. C.K. Chang, W.C. Hung, and H.C. Chang The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo J. Cell Mol. Med. 12 2008 2781 2789
47. Y. Yang, R. Chaerkady, M.A. Beer, J.T. Mendell, and A. Pandey Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach Proteomics 9 2009 1374 1384
48. L.B. Frankel, N.R. Christoffersen, A. Jacobsen, M. Lindow, A. Krogh, and A.H. Lund Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells J. Biol. Chem. 283 2008 1026 1033
49. F. Meng, R. Henson, H. Wehbe-Janek, K. Ghoshal, S.T. Jacob, and T. Patel MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer Gastroenterology 133 2007 647 658
50. M.L. Si, S. Zhu, H. Wu, Z. Lu, F. Wu, and Y.Y. Mo miR-21-mediated tumor growth Oncogene 26 2007 2799 2803
51. T. Miki, A. Shamma, S. Kitajima, Y. Takegami, M. Noda, Y. Nakashima, K. Watanabe, and C. Takahashi The ss1-integrin-dependent function of RECK in physiologic and tumor angiogenesis Mol. Cancer Res. 8 2010 665 676
52. K.J. Hong, M.C. Hsu, M.F. Hou, and W.C. Hung The tumor suppressor RECK interferes with HER-2/Neu dimerization and attenuates its oncogenic signaling FEBS Lett. 585 2011 591 595